High breast, colorectal and urology cancer rates in the Morecambe Bay area compared with North West and England averages


The study also found that people in Barrow-in-Furness are at the highest risk of developing any type of cancer compared within the Morecambe Bay region or the average of the North West overall
The study also found that people in Barrow-in-Furness are at the highest risk of developing any type of cancer compared within the Morecambe Bay region or the average of the North West overall

The Morecambe Bay area has the highest rate of common cancers compared with the average rates for the whole North West or even England according to researchers.

However, average cancer rates for other areas like Manchester and Liverpool have not yet been analysed by statisticians so this does not mean that Morecambe Bay is the worst in the region or in England, but that it compares poorly with the average rates for the North West and England.

The three types of cancer which are higher in the Morecambe Bay area are breast, bowel and urological - which includes prostate, kidney, bladder, testicular and penile cancers.

The area covered by the University Hospitals of Morecambe Bay NHS Foundation Trust includes Morecambe and Lancaster in Lancashire plus Kendal, Ulverston, and Barrow-in- Furness in Cumbria.

The study also found that people in Barrow-in-Furness are at the highest risk of developing any type of cancer compared within the Morecambe Bay region or the average of the North West overall. The risk in Barrow-in-Furness was three times greater than the risk for people living in surrounding rural areas and higher than for similar urban areas in Morecambe and Lancaster. Differences between regions demonstrated that rural areas were least impacted by cancer. Morecambe, Lancaster and Barrow-in-Furness, had a higher risk of cancer up to six times greater than the risk of cancer in the more rural areas of Windermere West, Burton in Lonsdale and Quernmore.

Factors influencing the risk of a cancer diagnosis were age, deprivation, ethnicity, frailty, and additional illnesses.

The research published in Public Health in Practice, the journal of the Royal Society for Public Health, analysed 15,506 cancer diagnoses in the Morecambe Bay area between 2017 to 2022.

Lead author Dr Luigi Sedda from the Lancaster Ecology and Epidemiology Group at Lancaster Medical School said: “Research needs to be carried out to gain a better understanding of why this is the case and what can be done to reduce these differences in the areas that need it most.

“Understanding which areas have a high number of cancer cases, the geographic, socio-economic, and demographic drivers for the presence of multiple cancers in an area, is essential to develop efficient and integrated interventions.

“Area specific programmes need to be put in place which target the specific risk factors and cancer types of an area, with programmes focusing first on locations with the largest risk and incidence of cancer, such as Barrow in Furness. These programmes could include, for example, mobile screening units to increase early diagnosis, increased awareness of the signs and symptoms of cancer within workplaces, and increasing access to exercise, support to stop smoking and dietary advice within local communities. Working with the local communities is essential for the success of these interventions.”

Figure for 2016 show that breast cancer was the most common cancer for women, prostate cancer the most common for men while bowel cancer was the third most common cancer for both men and women according to the Office for National Statistics.

The research was funded by North West Cancer Research (NWCR) and led by the Lancaster Ecology and Epidemiology Group at Lancaster Medical School in collaboration with Liverpool John Moores University, Queen’s University Belfast, and University Hospitals of Morecambe Bay NHS Foundation Trust.

The other authors included Dr Thomas Keegan from Lancaster Medical School, Professor Peter Atkinson from Lancaster University Faculty of Science and Technology, Alison Birtles from Rosemere Cancer Centre at Lancashire Teaching Hospitals NHS Trust and the University Hospitals of Morecambe Bay NHS Foundation Trust, Jessica Mendes from the University of Oxford, Catherine Jones and Kelly Heys from the University Hospitals of Morecambe Bay NHS Foundation Trust and Andy Knox from Lancashire and Cumbria Integrated Care Board.

Back to News